Evidence map›Paper›PMID 38389521›Full record

ArticleGenetics research2024

Evaluation of the Expression of Infection-Related Long Noncoding RNAs among COVID-19 Patients: A Case-Control Study.

Zahra Firoozi, Elham Mohammadisoleimani, Farzaneh Bagheri, Atefeh Taheri, Babak Pezeshki, Mohammad Mehdi Naghizadeh, Abdolreza Daraei, Jalal Karimi, Yousef Gholampour, Yaser Mansoori and 1 more

Open access · goldAbstract read
In one paragraph

Article in Genetics research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Zahra FirooziDepartment of Medical Genetics, Fasa University of Medical Sciences, Fasa, Iran.ORCID 0000-0002-8103-2244
Elham MohammadisoleimaniUSERN Office, Fasa University of Medical Sciences, Fasa, Iran.ORCID 0000-0002-3950-3102
Farzaneh BagheriUSERN Office, Fasa University of Medical Sciences, Fasa, Iran.
Atefeh TaheriDepartment of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Babak PezeshkiDepartment of Internal Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Mohammad Mehdi NaghizadehNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.ORCID 0000-0001-5562-103X
Abdolreza DaraeiDepartment of Medical Genetics, School of Medicine, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0002-2106-835X
Jalal KarimiDepartment of Infectious Diseases, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Yousef GholampourDepartment of Internal Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Yaser MansooriDepartment of Medical Genetics, Fasa University of Medical Sciences, Fasa, Iran.ORCID 0000-0002-9101-5552
Zahra MontaseriDepartment of Infectious Diseases, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.ORCID 0000-0003-4031-199X
Fasa University of Medical Sciences · IRUniversal Scientific Education and Research Network · IRBabol University of Medical Sciences · IRIran University of Medical Sciences · IRKerman University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a worldwide pandemic, activates signaling cascades and leads to innate immune responses and secretion of multiple chemokines and cytokines. Long noncoding RNAs (lncRNAs) have a crucial role in inflammatory pathways. Through our search on the PubMed database, we discovered that existing research has primarily focused on examining the regulatory impacts of five lncRNAs in the context of viral infections. However, their role in regulating other conditions, including SARS-CoV-2, has not been explored. Therefore, this study aimed to investigate the expression pattern of lncRNAs in the peripheral blood mononuclear cells (PBMC) and their potential roles in SARS-CoV-2 infection. Potentially significant competing endogenous RNA (ceRNA) networks of these five lncRNAs were found using online in-silico techniques. Methods: Ethylenediaminetetraacetic acid (EDTA) blood samples of the control group consisted of 45 healthy people, and a total of 53 COVID-19-infected patients in case group, with a written informed consent, was collected. PBMCs were extracted, and then, the RNA extraction and complementary DNA (cDNA) synthesis was performed. The expression of five lncRNAs (lnc ISR, lnc ATV, lnc PAAN, lnc SG20, and lnc HEAL) was assessed by real-time PCR. In order to evaluate the biomarker roles of genes, receiver operating characteristic (ROC) curve was drawn. Results: Twenty-four (53.3%) and 29 (54.7%) of healthy and COVID-19-infected participants were male, respectively. The most prevalent symptoms were as follows: cough, general weakness, contusion, headache, and sore throat. The results showed that three lncRNAs, including lnc ISR, lnc ATV, and lnc HEAL, were expressed dramatically higher in the case group compared to healthy controls. According to ROC curve analysis, lnc ATV has a higher AUC and is a better biomarker to differentiate COVID-19 patients from the healthy controls. Then, using bioinformatics methods, the ceRNA network of these lncRNAs enabled the identification of mRNAs and miRNAs with crucial functions in COVID-19. Conclusion: The considerable higher expression of ISR, ATV, and HEAL lncRNAs and the significant area under curve (AUC) in ROC curve demonstrate that these RNAs probably have a potential role in controlling the host innate immune responses and regulate the viral replication of SARS-CoV-2. However, these assumptions need further in vitro and in vivo investigations to be confirmed.

Indexed as

COVID-19RNA, Long NoncodingBiomarkersCase-Control StudiesFemaleHumansLeukocytes, MononuclearMaleSARS-CoV-2BiomarkersRNA, Long Noncoding

Identifiers

PMID38389521
PMCPMC10883746
OpenAlexW4391844666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.